Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Breast Cancer

  Free Subscription


Articles published in Radiology

Retrieve available abstracts of 71 articles:
HTML format



Single Articles


    January 2022
  1. SHOSHAN Y, Bakalo R, Gilboa-Solomon F, Ratner V, et al
    Artificial Intelligence for Reducing Workload in Breast Cancer Screening with Digital Breast Tomosynthesis.
    Radiology. 2022 Jan 18:211105. doi: 10.1148/radiol.211105.
    PubMed     Abstract available


    December 2021
  2. FUCHSJAGER MH, Adelsmayr G
    Artificial Intelligence as an Assistant in Breast Cancer Screening.
    Radiology. 2021 Dec 14:212675. doi: 10.1148/radiol.212675.
    PubMed    


  3. GASTOUNIOTI A, Pantalone L, Scott CG, Cohen EA, et al
    Fully Automated Volumetric Breast Density Estimation from Digital Breast Tomosynthesis.
    Radiology. 2021;301:561-568.
    PubMed     Abstract available


  4. ZHU X, Wolfgruber TK, Leong L, Jensen M, et al
    Deep Learning Predicts Interval and Screening-detected Cancer from Screening Mammograms: A Case-Case-Control Study in 6369 Women.
    Radiology. 2021;301:550-558.
    PubMed     Abstract available


    November 2021
  5. FAN M, Cui Y, You C, Liu L, et al
    Radiogenomic Signatures of Oncotype DX Recurrence Score Enable Prediction of Survival in Estrogen Receptor-Positive Breast Cancer: A Multicohort Study.
    Radiology. 2021 Nov 30:210738. doi: 10.1148/radiol.2021210738.
    PubMed     Abstract available


  6. TICE JA, Gard CC, Miglioretti DL, Sprague BL, et al
    Comparing Mammographic Density Assessed by Digital Breast Tomosynthesis or Digital Mammography: The Breast Cancer Surveillance Consortium.
    Radiology. 2021 Nov 23:204579. doi: 10.1148/radiol.2021204579.
    PubMed     Abstract available


  7. MORI N, Mugikura S, Takase K
    Extra- or Peritumoral Hyperintensity on T2-weighted Images in Patients with Breast Cancer.
    Radiology. 2021 Nov 16:210939. doi: 10.1148/radiol.2021210939.
    PubMed    


  8. GEERTSE TD, Setz-Pels W, van der Waal D, Nederend J, et al
    Added Value of Prereading Screening Mammograms for Breast Cancer by Radiologic Technologists on Early Screening Outcomes.
    Radiology. 2021 Nov 9:210746. doi: 10.1148/radiol.2021210746.
    PubMed     Abstract available


  9. PISANO ED
    How Radiologists Can Improve Breast Cancer Screening.
    Radiology. 2021 Nov 9:211525. doi: 10.1148/radiol.2021211525.
    PubMed    


    October 2021
  10. HELLER SL
    Impact of the Pandemic on Breast Cancer Diagnoses.
    Radiology. 2021 Oct 19:212477. doi: 10.1148/radiol.2021212477.
    PubMed    


  11. HICKMAN SE, Woitek R, Le EPV, Im YR, et al
    Machine Learning for Workflow Applications in Screening Mammography: Systematic Review and Meta-Analysis.
    Radiology. 2021 Oct 19:210391. doi: 10.1148/radiol.2021210391.
    PubMed     Abstract available


  12. MANKOFF DA, Sellmyer MA
    PET of Fibroblast-Activation Protein for Breast Cancer Diagnosis and Staging.
    Radiology. 2021 Oct 12:212098. doi: 10.1148/radiol.2021212098.
    PubMed    


  13. BACKHAUS P, Burg MC, Roll W, Buther F, et al
    Simultaneous FAPI PET/MRI Targeting the Fibroblast-Activation Protein for Breast Cancer.
    Radiology. 2021 Oct 12:204677. doi: 10.1148/radiol.2021204677.
    PubMed     Abstract available


  14. VERBURG E, van Gils CH, van der Velden BHM, Bakker MF, et al
    Deep Learning for Automated Triaging of 4581 Breast MRI Examinations from the DENSE Trial.
    Radiology. 2021 Oct 5:203960. doi: 10.1148/radiol.2021203960.
    PubMed     Abstract available


    September 2021
  15. BAE MS, Kim HG
    Breast Cancer Risk Prediction Using Deep Learning.
    Radiology. 2021 Sep 7:211446. doi: 10.1148/radiol.2021211446.
    PubMed    


    August 2021
  16. ONISHI N, Li W, Newitt DC, Harnish RJ, et al
    Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response.
    Radiology. 2021 Aug 24:203645. doi: 10.1148/radiol.2021203645.
    PubMed     Abstract available


  17. IMBRIACO M
    Reducing False-Positive Screening MRI Rates in Women with Extremely Dense Breasts.
    Radiology. 2021 Aug 17:211547. doi: 10.1148/radiol.2021211547.
    PubMed    


  18. DEN DEKKER BM, Bakker MF, de Lange SV, Veldhuis WB, et al
    Reducing False-Positive Screening MRI Rate in Women with Extremely Dense Breasts Using Prediction Models Based on Data from the DENSE Trial.
    Radiology. 2021 Aug 17:210325. doi: 10.1148/radiol.2021210325.
    PubMed     Abstract available


  19. CHOU SS, Romanoff J, Lehman CD, Khan SA, et al
    Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial).
    Radiology. 2021 Aug 3:204743. doi: 10.1148/radiol.2021204743.
    PubMed     Abstract available


    July 2021
  20. LEE SH, Ryu HS, Jang MJ, Yi A, et al
    Glandular Tissue Component and Breast Cancer Risk in Mammographically Dense Breasts at Screening Breast US.
    Radiology. 2021 Jul 20:210367. doi: 10.1148/radiol.2021210367.
    PubMed     Abstract available


  21. BAE SJ, Cha YJ, Eun NL, Ji JH, et al
    Diagnostic Accuracy of Nonmass Enhancement at Breast MRI in Predicting Tumor Involvement of the Nipple: A Prospective Study in a Single Institution.
    Radiology. 2021 Jul 13:204136. doi: 10.1148/radiol.2021204136.
    PubMed     Abstract available


  22. CHAN HP, Helvie MA
    Using Single-View Wide-Angle DBT with AI for Breast Cancer Screening.
    Radiology. 2021 Jul 6:211203. doi: 10.1148/radiol.2021211203.
    PubMed    


  23. PINTO MC, Rodriguez-Ruiz A, Pedersen K, Hofvind S, et al
    Impact of Artificial Intelligence Decision Support Using Deep Learning on Breast Cancer Screening Interpretation with Single-View Wide-Angle Digital Breast Tomosynthesis.
    Radiology. 2021 Jul 6:204432. doi: 10.1148/radiol.2021204432.
    PubMed     Abstract available


    June 2021
  24. LEE CS, Moy L, Hughes D, Golden D, et al
    Radiologist Characteristics Associated with Interpretive Performance of Screening Mammography: A National Mammography Database (NMD) Study.
    Radiology. 2021 Jun 22:204379. doi: 10.1148/radiol.2021204379.
    PubMed     Abstract available


  25. SLANETZ PJ
    MRI Screening of Women with a Personal History of Breast Cancer.
    Radiology. 2021 Jun 8:211080. doi: 10.1148/radiol.2021211080.
    PubMed    


  26. KIM GR, Cho N, Kim SY, Han W, et al
    Interval Cancers after Negative Supplemental Screening Breast MRI Results in Women with a Personal History of Breast Cancer.
    Radiology. 2021 Jun 8:203074. doi: 10.1148/radiol.2021203074.
    PubMed     Abstract available


    May 2021
  27. CHANG JM
    MRI Screening Interval in Women with a History of Breast Cancer.
    Radiology. 2021 May 25:210836. doi: 10.1148/radiol.2021210836.
    PubMed    


  28. PARK VY, Kim MJ, Kim GR, Yoon JH, et al
    Outcomes Following Negative Screening MRI Results in Korean Women with a Personal History of Breast Cancer: Implications for the Next MRI Interval.
    Radiology. 2021 May 25:204217. doi: 10.1148/radiol.2021204217.
    PubMed     Abstract available


  29. MOY L, Gao Y
    Digital Mammography Is Similar to Screen-Film Mammography for Women with Personal History of Breast Cancer.
    Radiology. 2021 May 18:210930. doi: 10.1148/radiol.2021210930.
    PubMed    


  30. LEE JM, Ichikawa LE, Wernli KJ, Bowles E, et al
    Digital Mammography and Breast Tomosynthesis Performance in Women with a Personal History of Breast Cancer, 2007-2016.
    Radiology. 2021 May 18:204581. doi: 10.1148/radiol.2021204581.
    PubMed     Abstract available


  31. TAOUREL P
    Interval Breast Cancer after Digital Breast Tomosynthesis-based Screening: A Glimmer of Hope.
    Radiology. 2021 May 11:210179. doi: 10.1148/radiol.2021210179.
    PubMed    


  32. HOFVIND S, Moshina N, Holen AS, Danielsen AS, et al
    Interval and Subsequent Round Breast Cancer in a Randomized Controlled Trial Comparing Digital Breast Tomosynthesis and Digital Mammography Screening.
    Radiology. 2021 May 11:203936. doi: 10.1148/radiol.2021203936.
    PubMed     Abstract available


  33. RAYA-POVEDANO JL, Romero-Martin S, Elias-Cabot E, Gubern-Merida A, et al
    AI-based Strategies to Reduce Workload in Breast Cancer Screening with Mammography and Tomosynthesis: A Retrospective Evaluation.
    Radiology. 2021 May 4:203555. doi: 10.1148/radiol.2021203555.
    PubMed     Abstract available


    April 2021
  34. BYON JH, Park YV, Yoon JH, Moon HJ, et al
    Added Value of MRI for Invasive Breast Cancer including the Entire Axilla for Evaluation of High-Level or Advanced Axillary Lymph Node Metastasis in the Post-ACOSOG Z0011 Trial Era.
    Radiology. 2021 Apr 27:202683. doi: 10.1148/radiol.2021202683.
    PubMed     Abstract available


  35. PARK AR, Chae EY, Cha JH, Shin HJ, et al
    Preoperative Breast MRI in Women 35 Years of Age and Younger with Breast Cancer: Benefits in Surgical Outcomes by Using Propensity Score Analysis.
    Radiology. 2021 Apr 20:204124. doi: 10.1148/radiol.2021204124.
    PubMed     Abstract available


  36. MANN RM
    Tomosynthesis Is Taking Small Steps to Become the Standard for Breast Cancer Screening.
    Radiology. 2021 Apr 6:210153. doi: 10.1148/radiol.2021210153.
    PubMed    


  37. JOHNSON K, Lang K, Ikeda DM, Akesson A, et al
    Interval Breast Cancer Rates and Tumor Characteristics in the Prospective Population-based Malmo Breast Tomosynthesis Screening Trial.
    Radiology. 2021 Apr 6:204106. doi: 10.1148/radiol.2021204106.
    PubMed     Abstract available


    March 2021
  38. FEIG SA
    Influence of Patient Participation on Decreased Mortality from Screening Mammography.
    Radiology. 2021 Mar 30:210226. doi: 10.1148/radiol.2021210226.
    PubMed    


  39. LEE CS, Berg JM, Berg WA
    Cancer Yield Exceeds 2% for BI-RADS 3 Probably Benign Findings in Women Older Than 60 Years in the National Mammography Database.
    Radiology. 2021 Mar 30:204031. doi: 10.1148/radiol.2021204031.
    PubMed     Abstract available


  40. KIM SY, Cho N, Choi Y, Lee SH, et al
    Factors Affecting Pathologic Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer: Development and Validation of a Predictive Nomogram.
    Radiology. 2021 Mar 23:203871. doi: 10.1148/radiol.2021203871.
    PubMed     Abstract available


  41. MOY L, Gao Y
    Supplemental MRI in Extremely Dense Breasts: Sharp Reduction in False-Positive Rate in the Second Screening Round of the DENSE Trial.
    Radiology. 2021 Mar 16:210265. doi: 10.1148/radiol.2021210265.
    PubMed    


  42. VEENHUIZEN SGA, de Lange SV, Bakker MF, Pijnappel RM, et al
    Supplemental Breast MRI for Women with Extremely Dense Breasts: Results of the Second Screening Round of the DENSE Trial.
    Radiology. 2021 Mar 16:203633. doi: 10.1148/radiol.2021203633.
    PubMed     Abstract available


  43. DUFFY SW, Tabar L, Yen AM, Dean PB, et al
    Beneficial Effect of Consecutive Screening Mammography Examinations on Mortality from Breast Cancer: A Prospective Study.
    Radiology. 2021 Mar 2:203935. doi: 10.1148/radiol.2021203935.
    PubMed     Abstract available


  44. JOCHELSON MS, Lobbes MBI
    Contrast-enhanced Mammography: State of the Art.
    Radiology. 2021 Mar 2:201948. doi: 10.1148/radiol.2021201948.
    PubMed     Abstract available


    February 2021
  45. OZUTEMIZ C, Krystosek LA, Church AL, Chauhan A, et al
    Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncology Patients.
    Radiology. 2021 Feb 24:210275. doi: 10.1148/radiol.2021210275.
    PubMed     Abstract available


  46. KWON MR, Choi JS, Won H, Ko EY, et al
    Breast Cancer Screening with Abbreviated Breast MRI: 3-year Outcome Analysis.
    Radiology. 2021 Feb 23:202927. doi: 10.1148/radiol.2021202927.
    PubMed     Abstract available


  47. ZARIC O, Farr A, Minarikova L, Lachner S, et al
    Tissue Sodium Concentration Quantification at 7.0-T MRI as an Early Marker for Chemotherapy Response in Breast Cancer: A Feasibility Study.
    Radiology. 2021 Feb 16:201600. doi: 10.1148/radiol.2021201600.
    PubMed     Abstract available


  48. HARADA TL, Uematsu T, Nakashima K, Kawabata T, et al
    Evaluation of Breast Edema Findings at T2-weighted Breast MRI Is Useful for Diagnosing Occult Inflammatory Breast Cancer and Can Predict Prognosis after Neoadjuvant Chemotherapy.
    Radiology. 2021 Feb 9:202604. doi: 10.1148/radiol.2021202604.
    PubMed     Abstract available


  49. HENDRICK RE, Helvie MA, Monticciolo DL
    Breast Cancer Mortality Rates Have Stopped Declining in U.S. Women Younger than 40 Years.
    Radiology. 2021 Feb 9:203476. doi: 10.1148/radiol.2021203476.
    PubMed     Abstract available


    January 2021
  50. RAHBAR H
    Closing the Chapter on Supplemental Breast Cancer Screening with US.
    Radiology. 2021 Jan 12:204334. doi: 10.1148/radiol.2021204334.
    PubMed    


  51. YI A, Jang MJ, Yim D, Kwon BR, et al
    Addition of Screening Breast US to Digital Mammography and Digital Breast Tomosynthesis for Breast Cancer Screening in Women at Average Risk.
    Radiology. 2021 Jan 12:203134. doi: 10.1148/radiol.2021203134.
    PubMed     Abstract available


  52. BAE MS
    Sustainable Benefits of Digital Breast Tomosynthesis Screening.
    Radiology. 2021;298:58-59.
    PubMed    


  53. EL KHOURY M, Maietta A, Tran A, Trop I, et al
    Case 285: Primary Breast Lymphoma.
    Radiology. 2021;298:231-236.
    PubMed     Abstract available


    December 2020
  54. BAHL M, Mercaldo S, McCarthy AM, Lehman CD, et al
    Imaging Surveillance of Breast Cancer Survivors with Digital Mammography versus Digital Breast Tomosynthesis.
    Radiology. 2020 Dec 22:201854. doi: 10.1148/radiol.2020201854.
    PubMed     Abstract available


  55. HOOLEY R, Butler R
    Digital Breast Tomosynthesis May Not Provide Optimal Surveillance of Breast Cancer Survivors.
    Radiology. 2020 Dec 22:204219. doi: 10.1148/radiol.2020204219.
    PubMed    


  56. DURAND MA, Friedewald SM, Plecha DM, Copit DS, et al
    False-Negative Rates of Breast Cancer Screening with and without Digital Breast Tomosynthesis.
    Radiology. 2020 Dec 1:202858. doi: 10.1148/radiol.2020202858.
    PubMed     Abstract available


  57. PUJARA AC, Joe AI, Patterson SK, Neal CH, et al
    Digital Breast Tomosynthesis Slab Thickness: Impact on Reader Performance and Interpretation Time.
    Radiology. 2020;297:534-542.
    PubMed     Abstract available


  58. SCHATTNER E
    High-Quality Mammography: A Step Forward for Women's Health.
    Radiology. 2020 Dec 1:204087. doi: 10.1148/radiol.2020204087.
    PubMed    


    November 2020
  59. MCDONALD ES, Romanoff J, Rahbar H, Kitsch AE, et al
    Mean Apparent Diffusion Coefficient Is a Sufficient Conventional Diffusion-weighted MRI Metric to Improve Breast MRI Diagnostic Performance: Results from the ECOG-ACRIN Cancer Research Group A6702 Diffusion Imaging Trial.
    Radiology. 2020 Nov 17:202465. doi: 10.1148/radiol.2020202465.
    PubMed     Abstract available


  60. CAUMO F, Montemezzi S, Romanucci G, Brunelli S, et al
    Repeat Screening Outcomes with Digital Breast Tomosynthesis Plus Synthetic Mammography for Breast Cancer Detection: Results from the Prospective Verona Pilot Study.
    Radiology. 2020 Nov 10:201246. doi: 10.1148/radiol.2020201246.
    PubMed     Abstract available


    October 2020
  61. KOSMIN M, Padhani AR, Gogbashian A, Woolf D, et al
    Comparison of Whole-Body MRI, CT, and Bone Scintigraphy for Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to Bone.
    Radiology. 2020 Oct 20:192683. doi: 10.1148/radiol.2020192683.
    PubMed     Abstract available


  62. JIANG Y, Edwards AV, Newstead GM
    Artificial Intelligence Applied to Breast MRI for Improved Diagnosis.
    Radiology. 2020 Oct 20:200292. doi: 10.1148/radiol.2020200292.
    PubMed     Abstract available


  63. ZUCKERMAN SP, Sprague BL, Weaver DL, Herschorn SD, et al
    Multicenter Evaluation of Breast Cancer Screening with Digital Breast Tomosynthesis in Combination with Synthetic versus Digital Mammography.
    Radiology. 2020 Oct 13:200240. doi: 10.1148/radiol.2020200240.
    PubMed     Abstract available


  64. LANG K
    Mounting Evidence for Synthetic Mammography in Breast Cancer Screening.
    Radiology. 2020 Oct 13:203716. doi: 10.1148/radiol.2020203716.
    PubMed    


    September 2020
  65. MOSHINA N, Aase HS, Danielsen AS, Haldorsen IS, et al
    Comparing Screening Outcomes for Digital Breast Tomosynthesis and Digital Mammography by Automated Breast Density in a Randomized Controlled Trial: Results from the To-Be Trial.
    Radiology. 2020 Sep 15:201150. doi: 10.1148/radiol.2020201150.
    PubMed     Abstract available


  66. CHUNG M, Hayward JH, Woodard GA, Knobel A, et al
    US as the Primary Imaging Modality in the Evaluation of Palpable Breast Masses in Breastfeeding Women, Including Those of Advanced Maternal Age.
    Radiology. 2020 Sep 1:201036. doi: 10.1148/radiol.2020201036.
    PubMed     Abstract available


    August 2020
  67. MCKAY JA, Church AL, Rubin N, Emory TH, et al
    A Comparison of Methods for High-Spatial-Resolution Diffusion-weighted Imaging in Breast MRI.
    Radiology. 2020 Aug 25:200221. doi: 10.1148/radiol.2020200221.
    PubMed     Abstract available


    July 2020
  68. BROWN AL, Wahab RA
    MRI of Primary Angiosarcoma of the Breast.
    Radiology. 2020 Jul 28:201377. doi: 10.1148/radiol.2020201377.
    PubMed    


  69. SALIM M, Dembrower K, Eklund M, Lindholm P, et al
    Range of Radiologist Performance in a Population-based Screening Cohort of 1 Million Digital Mammography Examinations.
    Radiology. 2020 Jul 28:192212. doi: 10.1148/radiol.2020192212.
    PubMed     Abstract available


  70. MOY L
    BI-RADS Category 3 Is a Safe and Effective Alternative to Biopsy or Surgical Excision.
    Radiology. 2020;296:42-43.
    PubMed    


    May 2020
  71. BERG WA, Berg JM, Sickles EA, Burnside ES, et al
    Cancer Yield and Patterns of Follow-up for BI-RADS Category 3 after Screening Mammography Recall in the National Mammography Database.
    Radiology. 2020 May 19:192641. doi: 10.1148/radiol.2020192641.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: